Zdrowie i gospodarka · 28/09/2015
FDA Publishes Draft Guidance on DNA Reactive Impurities in Pharmaceuticals
The FDA has released a draft guidance on acceptable intake limits for mutagenic and carcinogenic chemicals used in pharmaceutical manufacturing, under the International Conference on Harmonisation (ICH) framework.
Source: Federal Register — Food and Drug AdministrationOpen original release →